Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 90 Pages
Report ld: 3474238
Request Sample
Customized Report
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
In Europe, Mildronate Dihydrate key players include Grindeks, etc. Global top one manufacturers hold a share over 99%.
Russia is the largest market, with a share about 40%, followed by Latvia, and Lithuania, both have a share over 5 percent.
In terms of product, Capsule is the largest segment, with a share over 55%. And in terms of application, the largest application is Cardiovascular Disease, etc.
This report aims to provide a comprehensive presentation of the global market for Mildronate Dihydrate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mildronate Dihydrate by region & country, by Type, and by Application.
The Mildronate Dihydrate market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mildronate Dihydrate.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Mildronate Dihydrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Mildronate Dihydrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Mildronate Dihydrate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Mildronate Dihydrate Product Introduction
1.2 Global Mildronate Dihydrate Market Size Forecast
1.2.1 Global Mildronate Dihydrate Sales Value (2020-2031)
1.2.2 Global Mildronate Dihydrate Sales Volume (2020-2031)
1.2.3 Global Mildronate Dihydrate Sales Price (2020-2031)
1.3 Mildronate Dihydrate Market Trends & Drivers
1.3.1 Mildronate Dihydrate Industry Trends
1.3.2 Mildronate Dihydrate Market Drivers & Opportunity
1.3.3 Mildronate Dihydrate Market Challenges
1.3.4 Mildronate Dihydrate Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mildronate Dihydrate Players Revenue Ranking (2024)
2.2 Global Mildronate Dihydrate Revenue by Company (2020-2025)
2.3 Global Mildronate Dihydrate Players Sales Volume Ranking (2024)
2.4 Global Mildronate Dihydrate Sales Volume by Company Players (2020-2025)
2.5 Global Mildronate Dihydrate Average Price by Company (2020-2025)
2.6 Key Manufacturers Mildronate Dihydrate Manufacturing Base and Headquarters
2.7 Key Manufacturers Mildronate Dihydrate Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Mildronate Dihydrate
2.9 Mildronate Dihydrate Market Competitive Analysis
2.9.1 Mildronate Dihydrate Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Mildronate Dihydrate Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mildronate Dihydrate as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Capsule
3.1.2 Injection
3.1.3 Tablet
3.2 Global Mildronate Dihydrate Sales Value by Type
3.2.1 Global Mildronate Dihydrate Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Mildronate Dihydrate Sales Value, by Type (2020-2031)
3.2.3 Global Mildronate Dihydrate Sales Value, by Type (%) (2020-2031)
3.3 Global Mildronate Dihydrate Sales Volume by Type
3.3.1 Global Mildronate Dihydrate Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Mildronate Dihydrate Sales Volume, by Type (2020-2031)
3.3.3 Global Mildronate Dihydrate Sales Volume, by Type (%) (2020-2031)
3.4 Global Mildronate Dihydrate Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cardiovascular Disease
4.1.2 Others
4.2 Global Mildronate Dihydrate Sales Value by Application
4.2.1 Global Mildronate Dihydrate Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Mildronate Dihydrate Sales Value, by Application (2020-2031)
4.2.3 Global Mildronate Dihydrate Sales Value, by Application (%) (2020-2031)
4.3 Global Mildronate Dihydrate Sales Volume by Application
4.3.1 Global Mildronate Dihydrate Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Mildronate Dihydrate Sales Volume, by Application (2020-2031)
4.3.3 Global Mildronate Dihydrate Sales Volume, by Application (%) (2020-2031)
4.4 Global Mildronate Dihydrate Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Mildronate Dihydrate Sales Value by Region
5.1.1 Global Mildronate Dihydrate Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Mildronate Dihydrate Sales Value by Region (2020-2025)
5.1.3 Global Mildronate Dihydrate Sales Value by Region (2026-2031)
5.1.4 Global Mildronate Dihydrate Sales Value by Region (%), (2020-2031)
5.2 Global Mildronate Dihydrate Sales Volume by Region
5.2.1 Global Mildronate Dihydrate Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Mildronate Dihydrate Sales Volume by Region (2020-2025)
5.2.3 Global Mildronate Dihydrate Sales Volume by Region (2026-2031)
5.2.4 Global Mildronate Dihydrate Sales Volume by Region (%), (2020-2031)
5.3 Global Mildronate Dihydrate Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Mildronate Dihydrate Sales Value, 2020-2031
5.4.2 North America Mildronate Dihydrate Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Mildronate Dihydrate Sales Value, 2020-2031
5.5.2 Europe Mildronate Dihydrate Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Mildronate Dihydrate Sales Value, 2020-2031
5.6.2 Asia Pacific Mildronate Dihydrate Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Mildronate Dihydrate Sales Value, 2020-2031
5.7.2 South America Mildronate Dihydrate Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Mildronate Dihydrate Sales Value, 2020-2031
5.8.2 Middle East & Africa Mildronate Dihydrate Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mildronate Dihydrate Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Mildronate Dihydrate Sales Value
6.2.1 Key Countries/Regions Mildronate Dihydrate Sales Value, 2020-2031
6.2.2 Key Countries/Regions Mildronate Dihydrate Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Mildronate Dihydrate Sales Value, 2020-2031
6.3.2 United States Mildronate Dihydrate Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Mildronate Dihydrate Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Mildronate Dihydrate Sales Value, 2020-2031
6.4.2 Europe Mildronate Dihydrate Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Mildronate Dihydrate Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Mildronate Dihydrate Sales Value, 2020-2031
6.5.2 China Mildronate Dihydrate Sales Value by Type (%), 2024 VS 2031
6.5.3 China Mildronate Dihydrate Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Mildronate Dihydrate Sales Value, 2020-2031
6.6.2 Japan Mildronate Dihydrate Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Mildronate Dihydrate Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Mildronate Dihydrate Sales Value, 2020-2031
6.7.2 South Korea Mildronate Dihydrate Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Mildronate Dihydrate Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Mildronate Dihydrate Sales Value, 2020-2031
6.8.2 Southeast Asia Mildronate Dihydrate Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Mildronate Dihydrate Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Mildronate Dihydrate Sales Value, 2020-2031
6.9.2 India Mildronate Dihydrate Sales Value by Type (%), 2024 VS 2031
6.9.3 India Mildronate Dihydrate Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Grindeks
7.1.1 Grindeks Company Information
7.1.2 Grindeks Introduction and Business Overview
7.1.3 Grindeks Mildronate Dihydrate Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Grindeks Mildronate Dihydrate Product Offerings
7.1.5 Grindeks Recent Development
8 Industry Chain Analysis
8.1 Mildronate Dihydrate Industrial Chain
8.2 Mildronate Dihydrate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mildronate Dihydrate Sales Model
8.5.2 Sales Channel
8.5.3 Mildronate Dihydrate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Mildronate Dihydrate market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 71
USD 4250.00
(Single User License)
The global Mildronate Dihydrate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 95
USD 2900.00
(Single User License)
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 85
USD 3950.00
(Single User License)
The global Mildronate Dihydrate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 122
USD 4900.00
(Single User License)
In 2024, the global market size of Mildronate Dihydrate was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 116
USD 5900.00
(Single User License)
The global Mildronate Dihydrate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 67
USD 4250.00
(Single User License)
The global market for Mildronate Dihydrate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 68
USD 2900.00
(Single User License)
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published Date: 2024-04-17
Pages: 122
USD 5600.00
(Single User License)
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published Date: 2024-04-16
Pages: 121
USD 5900.00
(Single User License)
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published Date: 2024-04-07
Pages: 71
USD 4900.00
(Single User License)
The global Mildronate Dihydrate market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 71
The global Mildronate Dihydrate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 95
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 85
The global Mildronate Dihydrate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 122
In 2024, the global market size of Mildronate Dihydrate was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 116
The global Mildronate Dihydrate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 67
The global market for Mildronate Dihydrate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 68
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published: 2024-04-17
Pages: 122
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published: 2024-04-16
Pages: 121
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published: 2024-04-07
Pages: 71
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now